ImmunologybioRxivPreprint
BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response
J. C. Baray, M. M. R. Khan, A. Mahmud…·K. Nag
This paper develops and characterizes an mRNA-LNP vaccine candidate targeting the D614G variant of SARS-CoV-2, showing neutralizing antibody and balanced cellular immune responses in preclinical trials.
DOI 10.1101/2020.09.29.319061